The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18.
Open accessAbstract
The E6 protein of human papillomavirus types 16 and 18 (HPV-16 and HPV-18) can stably associate with the p53 protein in vitro. In the presence of rabbit reticulocyte lysate, this association leads to the specific degradation of p53 through the ubiquitin-dependent proteolysis system. We have examined the E6-p53 complex in more detail and have found that association of E6 with p53 is mediated by an additional cellular factor. This factor is present in rabbit reticulocyte lysate, primary human keratinocytes and in each of five human cell lines examined. The factor is designated E6-AP, for E6-associated protein, based on the observation that the E6 proteins of HPV-16 and 18 can form a stable complex with the factor in the absence of p53, whereas p53 association with the factor can be detected only in the presence of E6. Gel filtration and coprecipitation experiments indicate that E6-AP is a monomeric protein of approximately 100 kDa.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Smith, D. B., & Johnson, K. S. (1988) · Gene · doi:10.1016/0378-1119(88)90005-4 · Cited by 5,844
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Self-citationThe human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product
Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017
Self-citationAssociation of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
Self-citationT antigen is bound to a host protein in SY40-transformed cells
Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,456
Cyclin is degraded by the ubiquitin pathway
Glotzer, M., Murray, A. W., & Kirschner, M. W. (1991) · Nature · doi:10.1038/349132a0 · Cited by 2,359
Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,814
Structure and transcription of human papillomavirus sequences in cervical carcinoma cells
Schwarz, E., Freese, U. K., Gissmann, L., Mayer, W., Roggenbuck, B., Stremlau, A., & Hausen, H. Z. (1985) · Nature · doi:10.1038/314111a0 · Cited by 1,483
DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J.-Y., Huang, C.-M., Lee, W.-H., Marsilio, E., Paucha, E., & Livingston, D. M. (1988) · Cell · doi:10.1016/0092-8674(88)90559-4 · Cited by 1,459
Whyte, P., Buchkovich, K. J., Horowitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A., & Harlow, E. (1988) · Nature · doi:10.1038/334124a0 · Cited by 1,403
Cited by
Sorted by citations
Items 601–700 of 879
Identification of an E3 ubiquitin-protein ligase in the softshell clam (Mya arenaria)
Kelley, M. L., & Beneden, R. J. V. (2000) · Marine Environmental Research · doi:10.1016/s0141-1136(00)00087-8 · Cited by 12
Holloway, A., & Storey, A. (2013) · Journal of General Virology · doi:10.1099/vir.0.057695-0 · Cited by 12
The Role of Ubiquitin and Ubiquitin-Like Modification Systems in Papillomavirus Biology
Wilson, V. G. (2014) · Viruses · doi:10.3390/v6093584 · Cited by 11
Harwood, C. A., Surentheran, T., McGregor, J., Spink, P. J., Leigh, I. M., Breuer, J., & Proby, C. M. (2000) · Journal of Medical Virology · doi:10.1002/1096-9071(200007)61:3 · Cited by 420
Targeting Ubiquitin-Mediated Degradation for Proliferation Inhibitors
Pagano, M., Beer‐Romero, P., Glass, S., Tam, S. W., Theodoras, A. M., Rolfe, M., & Draetta, G. F. (1996) · Springer eBooks · doi:10.1007/978-1-4615-5895-8_15 · Cited by 12
DARPin-induced reactivation of p53 in HPV-positive cells
Münick, P., Strubel, A., Balourdas, D.-I., Funk, J. S., Mernberger, M., Osterburg, C., Dreier, B., Schaefer, J. V., Tuppi, M., Yüksel, B., et al. (2025) · Nature Structural & Molecular Biology · doi:10.1038/s41594-024-01456-7 · Cited by 11
Miller, J., Dakic, A., Spurgeon, M. E., Sáenz, F., Kallakury, B., Zhao, B., Zhang, J., Zhu, J. K., Ma, Q., Xu, Y., et al. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27795 · Cited by 10
Iyer, K. S., Gaikwad, R. M., Woodworth, C. D., Volkov, D. O., & Sokolov, I. Y. (2012) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-012-9345-2 · Cited by 11
HPV Associated with Recurrent Respiratory Papillomatosis
Seedat, R. Y., Combrinck, C. E., & Burt, F. J. (2013) · Future Virology · doi:10.2217/fvl.13.31 · Cited by 11
Olberding, K. E., Kelley, M. L., Butler, R. A., & Beneden, R. J. V. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.06.004 · Cited by 11
Development of a Topical Protein Therapeutic for Human Papillomavirus and Associated Cancers
Green, K. L., & Gaston, K. (2006) · BioDrugs · doi:10.2165/00063030-200620040-00002 · Cited by 11
[Human papillomavirus and cervical cancer].
Kanda, T., & Kukimoto, I. (2006) · Uirusu · doi:10.2222/jsv.56.219 · Cited by 11
Ubiquitination of the p53 Tumor Suppressor
Huibregtse, J. M., Maki, C. G., & Howley, P. M. (1998) · Springer eBooks · doi:10.1007/978-1-4899-1922-9_11 · Cited by 11
Self-citationKaposi's Sarcoma-Associated Herpesvirus LANA Modulates the Stability of the E3 Ubiquitin Ligase RLIM
Tadmor, H., Greenway, M., Ahuja, A., Orgil, O., Liao, G., Ambinder, R. F., Hayward, S. D., & Shamay, M. (2019) · Journal of Virology · doi:10.1128/jvi.01578-19 · Cited by 10
Gao, L., Li, Y., Yu, C., Liu, D., Wu, K., Wei, Z.-L., Liu, M., & Yu, L. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.847793 · Cited by 10
Romero-Masters, J. C., Grace, M. R., Lee, D., Lei, J., DePamphilis, M., Buehler, D. G., Hu, R., Ward-Shaw, E. T., Blaine‐Sauer, S., Lavoie, N., et al. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011215 · Cited by 10
Kunos, C. A., & Radivoyevitch, T. (2012) · Gynecology & Obstetrics · doi:10.4172/2161-0932.s4-001 · Cited by 10
Structural Insights into Functional Modes of Proteins Involved in Ubiquitin Family Pathways
Hänzelmann, P., Schäfer, A., Völler, D., & Schindelin, H. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-474-2_39 · Cited by 10
Viral Transformation of Epithelial Cells
Regan, J. A., & Laimins, L. A. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-125-7_26 · Cited by 10
USP15 inhibits HPV16 E6 degradation and catalytically inactive USP15 has reduced inhibitory activity
Yaginuma, Y., YOSHIMOTO, M., & TOKUDA, A. (2018) · Acta Virologica · doi:10.4149/av_2018_204 · Cited by 10
Oncogenicitiy Comparison of Human Papillomavirus Type 52 E6 Variants
Lai, T. O., Boon, S. S., Law, P. T. Y., Chen, Z., Thomas, M., Banks, L., & Chan, P. K. S. (2019) · Journal of General Virology · doi:10.1099/jgv.0.001222 · Cited by 10
Telomere length and telomerase activity in the process of human fibroblast immortalization
Kumakura, S., Yamamoto, A., Yagisawa, J., Uchida, M., & Tsutsui, T. W. (2002) · Odontology · doi:10.1007/s102660200002 · Cited by 11
Folding and misfolding of the papillomavirus E6 interacting peptide E6ap
Cui, B., Shen, M., & Freed, K. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0431214100 · Cited by 10
Koide, N., Matsumoto, Y., Kosugi, S., Chou, D., Sakai∞, K., Hatakeyama, K., Niwa, O., & Kominami, R. (1999) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199901)24:1 · Cited by 4
Wendel, S. O., & Wallace, N. A. (2023) · mSphere · doi:10.1128/msphere.00427-23 · Cited by 10
Bravo, I. G., Belkhir, S., & Paget‐Bailly, P. (2024) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuae029 · Cited by 8
The Ubiquitin Ligase UBE3A Dampens ERK Pathway Signalling in HPV E6 Transformed HeLa Cells
Aguilar-Martínez, E., Morrisroe, C., & Sharrocks, A. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119366 · Cited by 9
Kim, D., Allwood, J. W., Moore, R. E., Marsden‐Edwards, E., Dunn, W. B., Yun Xu, A., Hampson, L., HAMPSON, I. N., & Goodacre, R. (2014) · Molecular BioSystems · doi:10.1039/c3mb70423h · Cited by 9
Bonhoure, A., Forster, A., Babah, K. O., Gógl, G., Eberling, P., Kostmann, C., Volkmer, R., Mancilla, V. E. T., Travé, G., & Nominé, Y. (2020) · Analytical Biochemistry · doi:10.1016/j.ab.2020.113772 · Cited by 9
Willemsen, A., van den Boom, A., Dietz, J., Dağalp, S. B., Doğan, F., Bravo, I. G., Ehrhardt, A., & Ehrke‐Schulz, E. (2020) · Virology Journal · doi:10.1186/s12985-020-01440-9 · Cited by 9
Wilkie, M. D., Anaam, E. A., Lau, A., Rubbi, C. P., Vlatković, N., Jones, T. M., & Boyd, M. T. (2021) · Cancers · doi:10.3390/cancers13194836 · Cited by 9
An overview of nuclear receptor coregulators involved in cerebellar development
Nishihara, E. (2008) · The Cerebellum · doi:10.1007/s12311-008-0018-z · Cited by 9
Delineation of the HPV11E6 and HPV18E6 Pathways in Initiating Cellular Transformation
Mwapagha, L. M., Tiffin, N., & Parker, M. I. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00258 · Cited by 9
Yanku, Y., Bitman-Lotan, E., Zohar, Y., Kurant, E., Zilke, N., Eilers, M., & Orian, A. (2018) · Cells · doi:10.3390/cells7100151 · Cited by 9
The function of the human papillomavirus oncogenes
Pim, D., Thomas, M., & Banks, L. (2001) · Perspectives in medical virology · doi:10.1016/s0168-7069(01)05006-6 · Cited by 9
Activities of the Transforming Proteins of Human Papillomaviruses
Nead, M. A., & McCance, D. J. (2014) · ASM Press eBooks · doi:10.1128/9781555818289.ch7 · Cited by 9
Chapter 25. Cell Cycle Control and Cancer
(1996) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)60464-9 · Cited by 9
Haas, A. L. (2007) · Wiley eBooks · doi:10.1002/9783527619320.ch5b · Cited by 8
From Genomic Imprinting to Developmental Physiology: Identifying Stepping Stones
Dan, B., Boyd, S. G., & Cheron, G. A. (2004) · Current Pharmacogenomics · doi:10.2174/1570160043377420 · Cited by 9
Cutaneous Human Papillomaviruses
Hazard, K. (2007) · Lund University Publications (Lund University) · Cited by 9
Kenny, S., Iyer, S., Gabel, C. A., Tegenfeldt, N. M., DeMarco, A. G., Hall, M. C., Chang, L., Davisson, V. J., Pol, S. V., & Das, C. (2025) · Structure · doi:10.1016/j.str.2024.12.013 · Cited by 7
Diacylglycerol Kinase ζ Attenuates Doxorubicin‐Induced Cardiotoxicity Through p53 Degradation
Tachibana, S., Otaki, Y., Watanabe, T., Goto, J., Ochi, H., Tanaka, T., Ono, H., Yamaguchi, R., Sato, J., Takahashi, H., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.035608 · Cited by 8
Beasley, S., Kellum, C. E., Orlomoski, R. J., Idrizi, F., & Spratt, D. E. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235925 · Cited by 8
Liddiard, K., Grimstead, J. W., Cleal, K., Evans, A., & Baird, D. M. (2021) · NAR Cancer · doi:10.1093/narcan/zcaa044 · Cited by 7
Viho, E. M. G., Punt, A. M., Distel, B., Houtman, R., Kroon, J., Elgersma, Y., & Meijer, O. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010303 · Cited by 7
HPV E6, E6AP and Cervical Cancer
Beaudenon, S. L. (2007) · Targeted Protein Database · doi:10.2970/tpdb.2007.67 · Cited by 8
Dhamodharan, P., Ponnusamy, N., Odumpatta, R., Sajitha Lulu, S., & Arumugam, M. (2018) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2018.8404 · Cited by 8
Role of Matrix and Cell Adhesion Molecules in Lens Differentiation
Menko, A. S., & Walker, J. L. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511529825.011 · Cited by 8
Khan, M. A., Canhoto, A. J., Housley, P. R., Creek, K. E., & Pirisi, L. A. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3729 · Cited by 8
Quinlan, R. A., & Prescott, A. R. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511529825.008 · Cited by 8
Bacterial ligases reveal fundamental principles of polyubiquitin specificity
Franklin, T. G., Brzović, P. S., & Pruneda, J. N. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.11.017 · Cited by 7
Palomino-Vizcaíno, G., Bañuelos-Villegas, E. G., & Álvarez-Salas, L. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312991 · Cited by 7
Therapeutic Mechanisms of Treatment in Cervical and Vaginal Cancer
AKunos, C. (2012) · touchREVIEWS in Oncology & Haematology · doi:10.17925/ohr.2012.08.1.55 · Cited by 7
Gagnon, D., & Archambault, J. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-2013-6_8 · Cited by 7
Association strength of E6 to E6AP/p53 complex correlates with HPV‐mediated oncogenesis risk
Ferraz, M. V. F., Viana, I. F. T., Coêlho, D. F., da Cruz, C. H. B., Lima, M. D. A., Aragão, M. A. D. L., & Lins, R. D. (2022) · Biopolymers · doi:10.1002/bip.23524 · Cited by 7
Xu, L., Müller, S., Thoppe, S. R., Hellborg, F., Kanter, L., Lerner, M., Zheng, B., Bajalica‐Lagercrantz, S., Grandér, D., Wallin, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111125 · Cited by 7
Neurodevelopmental Underpinnings of Angelman Syndrome
Li, G. (2014) · Journal of Bioanalysis & Biomedicine · doi:10.4172/1948-593x.1000111 · Cited by 6
Interaction of Papillomaviral Oncoproteins with Cellular Factors
Smola‐Hess, S., & Pfister, H. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-47650-9_14 · Cited by 7
Human papillomavirus E6 protein interactions
Thomas, M., Pim, D., & Banks, L. (2002) · Perspectives in medical virology · doi:10.1016/s0168-7069(02)08017-5 · Cited by 7
Human papillomavirus genital infection in modern gynecology: genetic and genomic aspects
Tinelli, A., Vergara, D., Leo, G., Malvası, A., Casciaro, S., Leo, E., Montinari, M. R., Maffia, M., Marsigliante, S., & Lorusso, V. (2007) · European Clinics in Obstetrics and Gynaecology · doi:10.1007/s11296-007-0064-y · Cited by 7
Transforming Proteins of Human Papillomaviruses
Ullman, C. G., & Emery, V. C. (1996) · Reviews in Medical Virology · doi:10.1002/(sici)1099-1654(199603)6:1 · Cited by 7
Lens Cell Proliferation: The Cell Cycle
Griep, A. E., & Zhang, P. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511529825.009 · Cited by 7
Elfiky, A. A., Saied, H. R., & Ali, M. A. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2270067 · Cited by 6
MmuPV1 E6 induces cell proliferation and other hallmarks of cancer
Romero-Masters, J. C., Muehlbauer, L. K., Hayes, M., Grace, M. R., Shishkova, E., Coon, J. J., Münger, K., & Lambert, P. F. (2023) · mBio · doi:10.1128/mbio.02458-23 · Cited by 5
Lambert, P. F., & Sugden, B. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00011-4 · Cited by 6
Ubiquitin-Dependent Protein Degradation
Hegde, A. N. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.02826-2 · Cited by 7
Transcription Factors in Early Lens Development
Goudreau, G., Bäumer, N., & Gruß, P. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511529825.004 · Cited by 6
The Impact of Human Papillomavirus Biology on the Clinical Practice of Cervical Pathology
Stoler, M. H. (2005) · Pathology Case Reviews · doi:10.1097/01.pcr.0000161169.34009.6c · Cited by 6
Zhou, Q., Yu, H., Dong, A., Yi, J., Li, J., Li, X., Zhou, L., Qiu, Q., Lü, B., Zhang, H., et al. (2025) · Neoplasia · doi:10.1016/j.neo.2025.101211 · Cited by 5
Ceramide-induced cleavage of GPR64 intracellular domain drives Ewing sarcoma
Suvarna, K., Jayabal, P., Ma, X., Wang, H., Chen, Y., Weintraub, S. T., Han, X., Houghton, P. J., & Shiio, Y. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114497 · Cited by 5
Shi, J., Chen, R.-Y., Liu, Y., Li, C.-Y., Yu, J. X., Tu, F.-Y., Sheng, J.-X., Lu, J., Zhang, L., Yang, G., et al. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111376 · Cited by 5
A TRIM21-based method for targeted protein degradation
Hu, W., Qiu, X., Yang, Y., Wu, Y., Wang, C., Hu, R., & Li, C. (2024) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2024179 · Cited by 5
E3 ubiquitin ligases in lung cancer: Emerging insights and therapeutic opportunities
Basu, B., Kal, S., Karmakar, S., Basu, M., & Ghosh, M. K. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122333 · Cited by 5
[Clinical and benign aspects of human papillomavirus-associated lesions].
Aubin, F., & Guerrini, J.-S. (2007) · PubMed · Cited by 5
Gong, Y., Xie, Y., Chen, L., Li, Y., & Sui, L. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-463 · Cited by 5
Deniz, Z., Uraz, S., Holem, R. R., Özaras, R., & Tahan, V. (2022) · Diseases · doi:10.3390/diseases10040094 · Cited by 5
Bouzid, A., Ani, M. A., de la Fuente, D., Shareef, Z. A., Quadri, A., Hamoudi, R., & Al-Rawi, N. H. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1128753 · Cited by 5
` Neurodevelopmental Underpinnings of Angelman Syndrome
Qiu, G. L. S. (2014) · OMICS Journal of Radiology · doi:10.4172/2167-7964.1000111 · Cited by 5
Oncogenes and antioncogenes in the development of HPV associated tumors
Crawford, L., & Tommasino, M. (1997) · Clinics in Dermatology · doi:10.1016/s0738-081x(96)00163-0 · Cited by 5
The interaction of azurin and C-terminal domain of p53 is mediated by nucleic acids
Xu, C., Zhao, Y., & Zhao, B. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.08.015 · Cited by 5
Basic science reviews: Tumor suppressor genes
Lee, N. K. (1992) · Head & Neck · doi:10.1002/hed.2880140513 · Cited by 5
Biological Pathways of HPV-Induced Carcinogenesis
Donà, M. G., & Tommasino, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-02200-6_18 · Cited by 4
Cervical cancer cell lines are sensitive to sub-erythemal UV exposure
Gu, W., Sun, S., Kahn, A., Dacus, D., Wendel, S. O., McMillan, N. A. J., & Wallace, N. A. (2018) · Gene · doi:10.1016/j.gene.2018.11.079 · Cited by 4
Çakır, M. O., Bilge, U., Ghanbari, A., & Ashrafi, G. H. (2023) · Pharmaceuticals · doi:10.3390/ph16121723 · Cited by 5
Highlights Of P53 Mutation And It's Role In Cervical Cancer Metastasis
Gracy.G, S. K. (2014) · Cited by 4
Seibert, K. N. (2013) · The Open Virology Journal · doi:10.2174/1874357901307010001 · Cited by 4
The Effect of Bacterial Peptide p28 on Viability and Apoptosis Statusof P53-null HeLa Cells
Abuei, H., Behzad‐Behbahani, A., Faghihi, F., Farhadi, A., Dehbidi, G. R., Pirouzfar, M., & Zare, F. (2019) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2019.078 · Cited by 4
Zhang, Y., Li, Y., Pan, E., Zhao, C., Zhang, H., Liu, R., Wang, S., Pu, Y., & Yin, L. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.1c00156 · Cited by 4
Kamstra, R. L., Dadgar, S., Wigg, J., Chowdhury, M. A., Phenix, C. P., & Floriano, W. B. (2014) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-014-9789-0 · Cited by 4
Strath, J., & Blair, G. E. (2006) · Acta Microbiologica et Immunologica Hungarica · doi:10.1556/amicr.53.2006.2.3 · Cited by 4
Ubiquitin-Dependent Protein Degradation
Hegde, A. N. (2010) · Elsevier eBooks · doi:10.1016/b978-008045382-8.00697-3 · Cited by 4
E7 protein of human papillomaviruses and its interaction with cellular pathways
Zehbe, I., Ciccolini, F., Orco, M. D., Pasquale, C., Zaccaro, F., Albarani, V., Marchini, A., Kanduc, D., & Tommasino, M. (1998) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8950-6_7 · Cited by 4
Howley, P. M., & DeMasi, J. (2008) · Elsevier eBooks · doi:10.1016/b978-141603703-3.10006-8 · Cited by 4
Self-citationCellular Regulation by Ubiquitin-Dependent Processes
Wilkinson, K. D. (1998) · Advances in molecular and cell biology · doi:10.1016/s1569-2558(08)60458-0 · Cited by 4
Haas, A. L. (2006) · Wiley eBooks · doi:10.1002/9783527620227.ch5 · Cited by 4
Human Papillomaviruses: Cervical Cancer and Warts
Deftereos, G., & Kiviat, N. B. (2014) · Springer eBooks · doi:10.1007/978-1-4899-7448-8_44 · Cited by 3
Lambert, P. F., & Sugden, B. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50014-2 · Cited by 3
Kim, S., Jo, K., Park, J., Shin, A., Kurita, R., Nakamura, Y., Kweon, S., & Baek, E. J. (2023) · Transfusion · doi:10.1111/trf.17394 · Cited by 3
Four conserved amino acids on human papillomavirus E6 predict clinical high‐risk types
Niiya, A., Hamaguchi, Y., Mishima, H., Miura, S., Komatsu, N., Nagata, K., Hasegawa, Y., Miura, K., & Yoshiura, K. (2023) · Journal of Medical Virology · doi:10.1002/jmv.29049 · Cited by 3
Chen, J., Zhang, X., Yan, S., Li, X., Li, M., Zhang, Y., Zhang, S., Li, F., & Song, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13154455 · Cited by 3
Metadata
- Authors
- Huibregtse, J. M., Scheffner, M., & Howley, P. M.
- Affiliations
- National Institutes of Health (US)
- Venue
- The EMBO Journal
- Published
- 1991-12-01
- Volume
- 10
- Issue
- 13
- Pages
- 4129-4135
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC453163
- OpenAlex
- W140061535
- Cited by
- 879
- References
- 46
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 16 · 2023: 26 · 2022: 21 · 2021: 25 · 2020: 27 · 2019: 18 · 2018: 28 · 2017: 29 · 2016: 19 · 2015: 26 · 2014: 29 · 2013: 28 · 2012: 41
- FWCI
- 5.96
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- The EMBO Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- p53, E6 oncoprotein, HPV16, HPV 18, UBE3A, ubiquitin-mediated proteolysis, p53 degradation, protein-protein interaction, keratinocytes, tumor suppressor
- MeSH terms
- Animals, Cell Line, Chromatography, Gel, DNA-Binding Proteins, Electrophoresis, Polyacrylamide Gel, Humans, Hydrolysis, Oncogene Proteins, Viral, Plasmids, Protein Binding, Proteins, Repressor Proteins, Reticulocytes, Tumor Suppressor Protein p53, Papillomaviridae
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review